The association of tea consumption with ovarian cancer risk: A metaanalysis.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 17905170.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This metaanalysis was undertaken to evaluate the relationship between tea intake and ovarian cancer risk. A systematic literature search up to September 2006 was performed in Medline, Embase, CANCERLIT, and the Cochrane Database. The summary relative risk was calculated. A sensitivity analysis was conducted to test the influence of each single study. Heterogeneity and publication bias were also evaluated. Two cohort and 7 case-control studies were included. The combined relative risk did not show that tea consumption was associated with a reduced ovarian cancer risk (relative risk, 0.84; 95% confidence interval, 0.66-1.07). When the analyses were stratified into subgroups, there was no evidence that study design substantially influenced the estimate of effects. The sensitivity analysis which means removing one study at a time confirmed the stability of our results. Our findings did not support that tea consumption was related to the decreased risk of ovarian cancer.
Medical subject headings
- Ovarian Neoplasms
- Tea